“Drug Development and FDA Review Process” From Michigan Medicine

Today. I reviewed and embed Michigan Medicine‘s Dementia For Scientists Module 5, Drug Development and FDA Review Process.

May 12, 2022

Dementia for Scientists Curriculum – Module 5: Therapy Development in Dementias

Judy Heidebrink, M.D., M.S., Richard and Katherine M. O’Connor Research Professor Alzheimer’s Disease

Posted in Alzheimer's Disease, Dementia, Dementia For Scientists From Michigan Medicine, Mild Cognitive Impairment, Minicourses | Comments Off on “Drug Development and FDA Review Process” From Michigan Medicine